Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

• Forschungsstelle: INNOSUISSE
• Projektnummer: 18024.1 PFLS-LS
• Projekttitel Englisch: Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Kurzbeschreibung (Deutsch)

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Kurzbeschreibung (Englisch)

Microfluidic two-tissue platform for combined drug efficacy and toxicity testing

Abstract (Deutsch)

Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.

Abstract (Englisch)

Development and commercialization of an end-user validated microphysiological testing platform for combined drug efficacy and toxicity testing. The platform will rely on microfluidics technology and will enable to metabolically interconnect active human 3D liver microtissues with microtissue tumor models. Handling, operation and read-out will be made compatible with cell culturing standards.